Asthma: The importance of dysregulated barrier immunity

European Journal of Immunology

Volumn 43, Issue 12, 2013, Pages 3125-3137

  Lambrecht, Bart N ^a,b,c   Hammad, Hamida ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Asthma; Lung inflammation; T cells

Indexed keywords

ALLERGEN; AMG 317; ANRUKINZUMAB; BRONCHODILATING AGENT; CYTOKINE; DUPILUMAB; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; MESSENGER RNA; NEUTRALIZING ANTIBODY; STEROID; THYMIC STROMAL LYMPHOPOIETIN; TRALOKINUMAB; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ADAPTIVE IMMUNITY; AIRWAY; ALLERGIC ASTHMA; ARTICLE; ASTHMA; BRONCHUS MUSCLE; CHRONIC DISEASE; CYTOKINE RELEASE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TARGETING; EOSINOPHILIA; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; INFLAMMATION; INNATE IMMUNITY; LUNG DISEASE; NONHUMAN; PATHOGENESIS; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SENSITIZATION; T LYMPHOCYTE; TH17 CELL; TH2 CELL; TREATMENT OUTCOME; ANIMAL; ANTIGEN PRESENTATION; DENDRITIC CELL; EPITHELIUM CELL; GOBLET CELL; IMMUNOLOGY; LUNG GAS EXCHANGE; MAST CELL; METAPLASIA; PATHOLOGY; PNEUMONIA; RESPIRATORY TRACT MUCOSA; REVIEW;

ASTHMA; LUNG INFLAMMATION; T CELLS;

ALLERGENS; ANIMALS; ANTIGEN PRESENTATION; ASTHMA; BLOOD-AIR BARRIER; CYTOKINES; DENDRITIC CELLS; EPITHELIAL CELLS; GOBLET CELLS; HUMANS; INFLAMMATION; MAST CELLS; METAPLASIA; RESPIRATORY MUCOSA; T-LYMPHOCYTES, REGULATORY;

EID: 84896955392     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343730     Document Type: Article

References (163)

1. Lloyd, C. M. and Hessel, E. M., Functions of T cells in asthma: more than just T(H)2 cells. Nat. Rev. Immunol. 2010. 10: 838-848.
2. Brusselle, G. G., Kips, J. C., Tavernier, J., Van Der Heyden, J. G., Cuvelier, C. A., Pauwels, R. A. and Bluethmann, H., Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin. Exp. Allergy 1994. 24: 73-80.
3. Wills-Karp, M., Luyimbazi, J, Xu, X., Schofield, B., Neben, T. Y., Karp, C. L. and Donaldson, D. D., Interleukin-13: central mediator of allergic asthma. Science 1998. 282: 2258-2261.
4. Webb, D. C., McKenzie, A. N., Koskinen, A. M., Yang, M., Mattes, J. and Foster, P. S., Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J. Immunol. 2000. 165: 108-113.
5. Humbles, A. A., Lloyd, C. M., McMillan, S. J., Friend, D. S., Xanthou, G., McKenna, E. E., Ghiran, S. et al., A critical role for eosinophils in allergic airways remodeling. Science 2004. 305: 1776-1779.
6. Cohn, L., Homer, R. J., Marinov, A., Rankin, J. and Bottomly, K., Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 1997. 186: 1737-1747.
7. Dolgachev, V., Petersen, B. C., Budelsky, A. L., Berlin, A. A. and Lukacs, N. W., Pulmonary IL-17E (IL-25) production and IL-17RB+ myeloid cell-derived Th2 cytokine production are dependent upon stem cell factor-induced responses during chronic allergic pulmonary disease. J. Immunol. 2009. 183: 5705-5715.
8. Hammad, H., Plantinga, M., Deswarte, K., Pouliot, P., Willart, M. A., Kool, M., Muskens, F. et al., Inflammatory dendritic cells-not basophils-are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J. Exp. Med. 2010. 207: 2097-2111.
9. Barlow, J. L., Bellosi, A., Hardman, C. S., Drynan, L. F., Wong, S. H., Cruickshank, J. P. and McKenzie, A. N., Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J. Allergy Clin. Immunol. 2012. 129: 191-198 e191-194.
10. Woodruff, P. G., Boushey, H. A., Dolganov, G. M., Barker, C. S., Yang, Y. H., Donnelly, S., Ellwanger, A. et al., Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc. Natl. Acad. Sci. USA 2007. 104: 15858-15863.
11. Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Koth, L. L. et al., T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am. J. Respir. Crit. Care Med. 2009. 180: 388-395.
12. Nair, P., Pizzichini, M. M., Kjarsgaard, M., Inman, M. D., Efthimiadis, A., Pizzichini, E., Hargreave, F. E. et al., Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N. Engl. J. Med. 2009. 360: 985-993.
13. Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P. et al., Mepolizumab and exacerbations of refractory eosinophilic asthma. N. Engl. J. Med. 2009. 360: 973-984.
14. Wang, Y. H., Voo, K. S., Liu, B., Chen, C. Y., Uygungil, B., Spoede, W., Bernstein, J. A. et al., A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J. Exp. Med. 2010. 207: 2479-2491.
15. Paul, W. E. and Zhu, J., How are T(H)2-type immune responses initiated and amplified? Nat. Rev. Immunol. 2010. 10: 225-235.
16. Mjosberg, J. and Spits, H., Type 2 innate lymphoid cells-new members of the "type 2 franchise" that mediate allergic airway inflammation. Eur. J. Immunol. 2012. 42: 1093-1096.
17. Klein Wolterink, R. G., Kleinjan, A., van Nimwegen, M., Bergen, I., de Bruijn, M., Levani, Y. and Hendriks, R. W., Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur. J. Immunol. 2012. 42: 1106-1116.
18. Kondo, Y., Yoshimoto, T., Yasuda, K., Futatsugi-Yumikura, S., Morimoto, M., Hayashi, N., Hoshino, T. et al., Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol. 2008. 20: 791-800.
19. Chang, Y. J., Kim, H. Y., Albacker, L. A., Baumgarth, N., McKenzie, A. N., Smith, D. E., Dekruyff, R. H. et al., Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 2011. 12: 631-638.
20. Bartemes, K. R., Iijima, K., Kobayashi, T., Kephart, G. M., McKenzie, A. N. and Kita, H., IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J. Immunol. 2012. 188: 1503-1513.
21. Kim, H. Y., Chang, Y. J., Subramanian, S., Lee, H. H., Albacker, L. A., Matangkasombut, P., Savage, P. B. et al., Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J. Allergy Clin. Immunol. 2012. 129: 216-227 e211-216.
22. Halim, T. Y., Krauss, R. H., Sun, A. C. and Takei, F., Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 2012. 36: 451-463.
23. Wilhelm, C., Hirota, K., Stieglitz, B., Van Snick, J., Tolaini, M., Lahl, K., Sparwasser, T. et al., An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat. Immunol. 2011. 12: 1071-1077.
24. Mjosberg, J., Bernink, J., Golebski, K., Karrich, J. J., Peters, C. P., Blom, B., Te Velde, A. A. et al., The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 2012. 37: 649-659.
25. Hoyler, T., Klose, C. S., Souabni, A., Turqueti-Neves, A., Pfeifer, D., Rawlins, E. L., Voehringer, D. et al., The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 2012. 37: 634-648.
26. Wong, S. H., Walker, J. A., Jolin, H. E., Drynan, L. F., Hams, E., Camelo, A., Barlow, J. L. et al., Transcription factor RORalpha is critical for nuocyte development. Nat. Immunol. 2012. 13: 229-236.
27. Halim, T. Y., MacLaren, A., Romanish, M. T., Gold, M. J., McNagny, K. M. and Takei, F., Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity 2012. 37: 463-474.
28. Klein Wolterink, R. G., Serafini, N., van Nimwegen, M., Vosshenrich, C. A., Fonseca-Pereira, D., Veiga-Fernandes, H., Hendriks, R. W. et al., An essential, dose-dependent role for the transcription factor GATA-3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells. Proc. Natl. Acad. Sci. USA 2013. 110: 10240-10245.
29. Doherty, T. A., Khorram, N., Chang, J. E., Kim, H. K., Rosenthal, P., Croft, M. and Broide, D. H., STAT6 regulates natural helper cell proliferation during lung inflammation initiated by Alternaria. Am. J. Physiol. Lung Cell Mol. Physiol. 2012. 303: L577-L588.
30. Barnig, C., Cernadas, M., Dutile, S., Liu, X., Perrella, M. A., Kazani, S., Wechsler, M. E. et al., Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci. Transl. Med. 2013. 5: 174ra126.
31. Lambrecht, B. N. and Hammad, H., The airway epithelium in asthma. Nat. Med. 2012. 18: 684-692.
32. Sokol, C. L., Chu, N. Q., Yu, S., Nish, S. A., Laufer, T. M. and Medzhitov, R., Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat. Immunol. 2009. 10: 713-720.
33. van Rijt, L. S., Vos, N., Hijdra, D., de Vries, V. C., Hoogsteden, H. C. and Lambrecht, B. N., Airway eosinophils accumulate in the mediastinal lymph nodes but lack antigen-presenting potential for naive T cells. J. Immunol. 2003. 171: 3372-3378.
34. Plantinga, M., Guilliams, M., Vanheerswynghels, M., Deswarte, K., Branco Madeira, F., Toussaint, W., Vanhoutte, L. et al., Conventional and monocyte-derived CD11b+ dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 2013. 38: 322-335.
35. Lambrecht, B. N. and Hammad, H., Lung dendritic cells in respiratory viral infection and asthma : from protection to immunopathology. Ann. Rev. Immunol. 2012. 30: 243-270.
36. Nakano, H., Free, M. E., Whitehead, G. S., Maruoka, S., Wilson, R. H., Nakano, K. and Cook, D. N., Pulmonary CD103(+) dendritic cells prime Th2 responses to inhaled allergens. Mucosal Immunol. 2012. 5: 53-65.
37. Mesnil, C., Sabatel, C. M., Marichal, T., Toussaint, M., Cataldo, D., Drion, P. V., Lekeux, P. et al., Resident CD11b(+)Ly6C(-) lung dendritic cells are responsible for allergic airway sensitization to house dust mite in mice. PLoS One 2012. 7: e53242.
38. Kool, M., van Nimwegen, M., Willart, M. A., Muskens, F., Boon, L., Smit, J. J., Coyle, A. et al., An anti-inflammatory role for plasmacytoid dendritic cells in allergic airway inflammation. J. Immunol. 2009. 183: 1074-1082.
39. de Heer, H. J., Hammad, H., Soullie, T., Hijdra, D., Vos, N., Willart, M. A., Hoogsteden, H. C. et al., Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 2004. 200: 89-98.
40. Hammad, H., Chieppa, M., Perros, F., Willart, M. A., Germain, R. N. and Lambrecht, B. N., House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat. Med. 2009. 15: 410-416.
41. Willart, M. A., Deswarte, K., Pouliot, P., Braun, H., Beyaert, R., Lambrecht, B. N. and Hammad, H., Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J. Exp. Med. 2012. 209: 1505-1517.
42. Phipps, S., Lam, C. E., Kaiko, G. E., Foo, S. Y., Collison, A., Mattes, J., Barry, J. et al., Toll/IL-1 signaling is critical for house dust mite-specific Th1 and Th2 responses. Am. J. Respir. Crit. Care Med. 2009. 179: 883-893.
43. Kool, M., Willart, M. A., van Nimwegen, M., Bergen, I., Pouliot, P., Virchow, J. C., Rogers, N. et al., An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. Immunity 2011. 34: 527-540.
44. Kato, A., Favoreto, S., Jr., Avila, P. C. and Schleimer, R. P., TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J. Immunol. 2007. 179: 1080-1087.
45. Ramadas, R. A., Li, X., Shubitowski, D. M., Samineni, S., Wills-Karp, M. and Ewart, S. L., IL-1 Receptor antagonist as a positional candidate gene in a murine model of allergic asthma. Immunogenetics 2006. 58: 851-855.
46. Caucig, P., Teschner, D., Dinges, S., Maxeiner, J. H., Reuter, S., Finotto, S., Taube, C. et al., Dual role of interleukin-1alpha in delayed-type hypersensitivity and airway hyperresponsiveness. Int. Arch. Allergy Immunol. 2010. 152: 303-312.
47. Schmitz, N., Kurrer, M. and Kopf, M., The IL-1 receptor 1 is critical for Th2 cell type airway immune responses in a mild but not in a more severe asthma model. Eur. J. Immunol. 2003. 33: 991-1000.
48. Allen, I. C., Jania, C. M., Wilson, J. E., Tekeppe, E. M., Hua, X., Brickey, W. J., Kwan, M. et al., Analysis of NLRP3 in the development of allergic airway disease in mice. J. Immunol. 2012. 188: 2884-2893.
49. Eisenbarth, S. C., Colegio, O. R., O'Connor, W., Sutterwala, F. S. and Flavell, R. A., Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 2008. 453: 1122-1126.
50. Kurowska-Stolarska, M., Stolarski, B., Kewin, P., Murphy, G., Corrigan, C. J., Ying, S., Pitman, N. et al., IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol. 2009. 183: 6469-6477.
51. Moffatt, M. F., Gut, I. G., Demenais, F., Strachan, D. P., Bouzigon, E., Heath, S., von Mutius, E. et al., A large-scale, consortium-based genomewide association study of asthma. N. Engl. J. Med. 2010. 363: 1211-1221.
52. Chu, D. K., Llop-Guevara, A., Walker, T. D., Flader, K., Goncharova, S., Boudreau, J. E., Moore, C. L. et al., IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J. Allergy Clin. Immunol. 2012. 131: 187-200.
53. Wills-Karp, M., Rani, R., Dienger, K., Lewkowich, I., Fox, J. G., Perkins, C., Lewis, L. et al., Trefoil factor 2 rapidly induces interleukin 33 to promote type 2 immunity during allergic asthma and hookworm infection. J. Exp. Med. 2012. 209: 607-622.
54. Besnard, A. G., Togbe, D., Guillou, N., Erard, F., Quesniaux, V. and Ryffel, B., IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur. J. Immunol. 2011. 41: 1675-1686.
55. Lambrecht, B. N., De Veerman, M., Coyle, A. J., Gutierrez-Ramos, J. C., Thielemans, K. and Pauwels, R. A., Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J. Clin. Invest. 2000. 106: 551-559.
56. Schneider, E., Petit-Bertron, A. F., Bricard, R., Levasseur, M., Ramadan, A., Girard, J. P., Herbelin, A. et al., IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production. J. Immunol. 2009. 183: 3591-3597.
57. Eiwegger, T. and Akdis, C. A., IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma. Eur. J. Immunol. 2011. 41: 1535-1538.
58. Hardman, C. S., Panova, V. and McKenzie, A. N., IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation. Eur. J. Immunol. 2012. 43: 488-498.
59. Luthi, A. U., Cullen, S. P., McNeela, E. A., Duriez, P. J., Afonina, I. S., Sheridan, C., Brumatti, G. et al., Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009. 31: 84-98.
60. Lambrecht, B. N. and Hammad, H., Death at the airway epithelium in asthma. Cell Res. 2013. 23: 588-589.
61. Lefrancais, E., Roga, S., Gautier, V., Gonzalez-de-Peredo, A., Monsarrat, B., Girard, J. P. and Cayrol, C., IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc. Natl. Acad. Sci. USA 2012. 109: 1673-1678.
62. Juncadella, I. J., Kadl, A., Sharma, A. K., Shim, Y. M., Hochreiter-Hufford, A., Borish, L. and Ravichandran, K. S., Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation. Nature 2013. 493: 547-551.
63. Zhao, J., Wei, J., Mialki, R. K., Mallampalli, D. F., Chen, B. B., Coon, T., Zou, C. et al., F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation. Nat. Immunol. 2012. 13: 651-658.
64. Corrigan, C. J., Wang, W., Meng, Q., Fang, C., Eid, G., Caballero, M. R., Lv, Z. et al., Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. J. Allergy Clin. Immunol. 2011. 128: 116-124.
65. Suzukawa, M., Morita, H., Nambu, A., Arae, K., Shimura, E., Shibui, A., Yamaguchi, S. et al., Epithelial cell-derived IL-25, but not Th17 cell-derived IL-17 or IL-17F, is crucial for murine asthma. J. Immunol. 2012. 189: 3641-3652.
66. Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S. et al., IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001. 15: 985-995.
67. Goswami, S., Angkasekwinai, P., Shan, M., Greenlee, K. J., Barranco, W. T., Polikepahad, S., Seryshev, A. et al., Divergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthma. Nat. Immunol. 2009. 10: 496-503.
68. Wang, Y. H., Angkasekwinai, P., Lu, N., Voo, K. S., Arima, K., Hanabuchi, S., Hippe, A. et al., IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J. Exp. Med. 2007. 204: 1837-1847.
69. Angkasekwinai, P., Park, H., Wang, Y. H., Wang, Y. H., Chang, S. H., Corry, D. B., Liu, Y. J. et al., Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med. 2007. 204: 1509-1517.
70. Kaiko, G. E., Phipps, S., Angkasekwinai, P., Dong, C. and Foster, P. S., NK cell deficiency predisposes to viral-induced Th2-type allergic inflammation via epithelial-derived IL-25. J. Immunol. 2010. 185: 4681-4690.
71. Angkasekwinai, P., Chang, S. H., Thapa, M., Watarai, H. and Dong, C., Regulation of IL-9 expression by IL-25 signaling. Nat. Immunol. 2010. 11: 250-256.
72. Petersen, B. C., Budelsky, A. L., Baptist, A. P., Schaller, M. A. and Lukacs, N. W., Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology. Nat. Med. 2012. 18: 751-758.
73. Gregory, L. G., Jones, C. P., Walker, S. A., Sawant, D., Gowers, K. H., Campbell, G. A., McKenzie, A. N. et al., IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax 2013. 68: 82-90.
74. Stampfli, M. R., Wiley, R. E., Scott Neigh, G., Gajewska, B. U., Lei, X. F., Snider, D. P., Xing, Z. et al., GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice. J. Clin. Invest. 1998. 102: 1704-1714.
75. Asquith, K. L., Ramshaw, H. S., Hansbro, P. M., Beagley, K. W., Lopez, A. F. and Foster, P. S., The IL-3/IL-5/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation. J. Immunol. 2008. 180: 1199-1206.
76. Ritz, S. A., Cundall, M. J., Gajewska, B. U., Alvarez, D., Gutierrez-Ramos, J. C., Coyle, A. J., McKenzie, A. N. et al., Granulocyte macrophage colony-stimulating factor-driven respiratory mucosal sensitization induces Th2 differentiation and function independently of interleukin-4. Am. J. Respir. Cell Mol. Biol. 2002. 27: 428-435.
77. Cates, E. C., Fattouh, R., Wattie, J., Inman, M. D., Goncharova, S., Coyle, A. J., Gutierrez-Ramos, J. C. et al., Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism. J. Immunol. 2004. 173: 6384-6392.
78. Ohta, K., Yamashita, N., Tajima, M., Miyasaka, T., Nakano, J., Nakajima, M., Ishii, A. et al., Diesel exhaust particulate induces airway hyperresponsiveness in a murine model: essential role of GM-CSF. J. Allergy Clin. Immunol. 1999. 104: 1024-1030.
79. Bleck, B., Tse, D. B., Jaspers, I., Curotto de Lafaille, M. A. and Reibman, J., Diesel exhaust particle-exposed human bronchial epithelial cells induce dendritic cell maturation. J. Immunol. 2006. 176: 7431-7437.
80. Zhou, B., Comeau, M. R., De Smedt, T., Liggitt, H. D., Dahl, M. E., Lewis, D. B., Gyarmati, D. et al., Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat. Immunol. 2005. 6: 1047-1053.
81. Ying, S., O'Connor, B., Ratoff, J., Meng, Q., Mallett, K., Cousins, D., Robinson, D. et al., Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J. Immunol. 2005. 174: 8183-8190.
82. Semlali, A., Jacques, E., Koussih, L., Gounni, A. S. and Chakir, J., Thymic stromal lymphopoietin-induced human asthmatic airway epithelial cell proliferation through an IL-13-dependent pathway. J. Allergy Clin. Immunol. 2010. 125: 844-850.
83. Harada, M., Hirota, T., Jodo, A. I., Hitomi, Y., Sakashita, M., Tsunoda, T., Miyagawa, T. et al., Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma. Am. J. Respir. Cell Mol. Biol. 2011. 44: 787-793.
84. Kouzaki, H., O'Grady, S. M., Lawrence, C. B. and Kita, H., Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J. Immunol. 2009. 183: 1427-1434.
85. Bleck, B., Tse, D. B., Gordon, T., Ahsan, M. R. and Reibman, J., Diesel exhaust particle-treated human bronchial epithelial cells upregulate Jagged-1 and OX40 ligand in myeloid dendritic cells via thymic stromal lymphopoietin. J. Immunol. 2010. 185: 6636-6645.
86. Zhang, Y., Zhou, X. and Zhou, B., DC-derived TSLP promotes Th2 polarization in LPS-primed allergic airway inflammation. Eur. J. Immunol. 2012. 42: 1735-1743.
87. Siracusa, M. C., Saenz, S. A., Hill, D. A., Kim, B. S., Headley, M. B., Doering, T. A., Wherry, E. J. et al., TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature 2011. 477: 229-233.
88. Wakashin, H., Hirose, K., Maezawa, Y., Kagami, S., Suto, A., Watanabe, N., Saito, Y. et al., IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am. J. Respir. Crit. Care Med. 2008. 178: 1023-1032.
89. Wilson, R. H., Whitehead, G. S., Nakano, H., Free, M. E., Kolls, J. K. and Cook, D. N., Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 2009. 180: 720-730.
90. Lajoie, S., Lewkowich, I. P., Suzuki, Y., Clark, J. R., Sproles, A. A., Dienger, K., Budelsky, A. L. et al., Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat. Immunol. 2010. 11: 928-935.
91. Kudo, M., Melton, A. C., Chen, C., Engler, M. B., Huang, K. E., Ren, X., Wang, Y. et al., IL-17A produced by alphabeta T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nat. Med. 2012. 18: 547-554.
92. Wang, Q., Li, H., Yao, Y., Xia, D. and Zhou, J., The overexpression of heparin-binding epidermal growth factor is responsible for Th17-induced airway remodeling in an experimental asthma model. J. Immunol. 2010. 185: 834-841.
93. Pichavant, M., Goya, S., Meyer, E. H., Johnston, R. A., Kim, H. Y., Matangkasombut, P., Zhu, M. et al., Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J. Exp. Med. 2008. 205: 385-393.
94. Bellini, A., Marini, M. A., Bianchetti, L., Barczyk, M., Schmidt, M. and Mattoli, S., Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients. Mucosal Immunol. 2012. 5: 140-149.
95. Zhao, J., Lloyd, C. M. and Noble, A., Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling. Mucosal Immunol. 2012. 6: 335-346.
96. Zijlstra, G. J., Ten Hacken, N. H., Hoffmann, R. F., van Oosterhout, A. J. and Heijink, I. H., Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells. Eur. Respir. J. 2012. 39: 439-445.
97. Moreira, A. P., Cavassani, K. A., Ismailoglu, U. B., Hullinger, R., Dunleavy, M. P., Knight, D. A., Kunkel, S. L. et al., The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A. J. Clin. Invest. 2011. 121: 4420-4432.
98. Schnyder-Candrian, S., Togbe, D., Couillin, I., Mercier, I., Brombacher, F., Quesniaux, V. F., Fossiez, F. et al., Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 2006. 203: 2715-2725.
99. Hoffjan, S., Stemmler, S., Parwez, Q., Petrasch-Parwez, E., Arinir, U., Rohde, G., Reinitz-Rademacher, K. et al., Evaluation of the toll-like receptor 6 Ser249Pro polymorphism in patients with asthma, atopic dermatitis and chronic obstructive pulmonary disease. BMC Med. Genet. 2005. 6: 34.
100. Ma, H. L., Liang, S., Li, J., Napierata, L., Brown, T., Benoit, S., Senices, M. et al., IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J. Clin. Invest. 2008. 118: 597-607.
101. Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J. and Ouyang, W., Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007. 445: 648-651.
102. Sugimoto, K., Ogawa, A., Mizoguchi, E., Shimomura, Y., Andoh, A., Bhan, A. K., Blumberg, R. S. et al., IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 2008. 118: 534-544.
103. Zhu, J., Cao, Y., Li, K., Wang, Z., Zuo, P., Xiong, W., Xu, Y. et al., Increased expression of aryl hydrocarbon receptor and interleukin 22 in patients with allergic asthma. Asian Pac. J. Allergy Immunol. 2011. 29: 266-272.
104. Taube, C., Tertilt, C., Gyulveszi, G., Dehzad, N., Kreymborg, K., Schneeweiss, K., Michel, E. et al., IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease. PLoS One 2011. 6: e21799.
105. Takahashi, K., Hirose, K., Kawashima, S., Niwa, Y., Wakashin, H., Iwata, A., Tokoyoda, K. et al., IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation. J. Allergy Clin. Immunol. 2011. 128: 1067-1076 e1061-1066.
106. Besnard, A. G., Sabat, R., Dumoutier, L., Renauld, J. C., Willart, M., Lambrecht, B., Teixeira, M. M. et al., Dual Role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A. Am. J. Respir. Crit. Care Med. 2011. 183: 1153-1163.
107. Pennino, D., Bhavsar, P. K., Effner, R., Avitabile, S., Venn, P., Quaranta, M., Marzaioli, V. et al., IL-22 suppresses IFN-gamma-mediated lung inflammation in asthmatic patients. J. Allergy Clin. Immunol. 2013. 131: 562-570.
108. Nakagome, K., Imamura, M., Kawahata, K., Harada, H., Okunishi, K., Matsumoto, T., Sasaki, O. et al., High expression of IL-22 suppresses antigen-induced immune responses and eosinophilic airway inflammation via an IL-10-associated mechanism. J. Immunol. 2011. 187: 5077-5089.
109. Huber, S., Gagliani, N., Zenewicz, L. A., Huber, F. J., Bosurgi, L., Hu, B., Hedl, M. et al., IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 2012. 491: 259-263.
110. Lilly, L. M., Gessner, M. A., Dunaway, C. W., Metz, A. E., Schwiebert, L., Weaver, C. T., Brown, G. D. et al., The beta-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22. J. Immunol. 2012. 189: 3653-3660.
111. Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B. et al., Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 2008. 9: 1341-1346.
112. Staudt, V., Bothur, E., Klein, M., Lingnau, K., Reuter, S., Grebe, N., Gerlitzki, B. et al., Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 2010. 33: 192-202.
113. Goswami, R., Jabeen, R., Yagi, R., Pham, D., Zhu, J., Goenka, S. and Kaplan, M. H., STAT6-dependent regulation of Th9 development. J. Immunol. 2012. 188: 968-975.
114. Elyaman, W., Bassil, R., Bradshaw, E. M., Orent, W., Lahoud, Y., Zhu, B., Radtke, F. et al., Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells. Immunity 2012. 36: 623-634.
115. Kearley, J., Erjefalt, J. S., Andersson, C., Benjamin, E., Jones, C. P., Robichaud, A., Pegorier, S. et al., IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am. J. Respir. Crit. Care Med. 2011. 183: 865-875.
116. Erpenbeck, V. J., Hohlfeld, J. M., Volkmann, B., Hagenberg, A., Geldmacher, H., Braun, A. and Krug, N., Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J. Allergy Clin. Immunol. 2003. 111: 1319-1327.
117. Temann, U. A., Ray, P. and Flavell, R. A., Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J. Clin. Invest. 2002. 109: 29-39.
118. Temann, U. A., Geba, G. P., Rankin, J. A. and Flavell, R. A., Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 1998. 188: 1307-1320.
119. Kerzerho, J., Maazi, H., Speak, A. O., Szely, N., Lombardi, V., Khoo, B., Geryak, S. et al., Programmed cell death ligand 2 regulates T(H)9 differentiation and induction of chronic airway hyperreactivity. J. Allergy Clin. Immunol. 2012. 131: 1048-1057.
120. Curotto de Lafaille, M. A., Kutchukhidze, N., Shen, S., Ding, Y., Yee, H. and Lafaille, J. J., Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 2008. 29: 114-126.
121. Josefowicz, S. Z., Niec, R. E., Kim, H. Y., Treuting, P., Chinen, T., Zheng, Y., Umetsu, D. T. et al., Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 2012. 482: 395-399.
122. Ostroukhova, M., Seguin-Devaux, C., Oriss, T. B., Dixon-McCarthy, B., Yang, L., Ameredes, B. T., Corcoran, T. E. et al., Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3. J. Clin. Invest. 2004. 114: 28-38.
123. Baru, A. M., Hartl, A., Lahl, K., Krishnaswamy, J. K., Fehrenbach, H., Yildirim, A. O., Garn, H. et al., Selective depletion of Foxp3+ Treg during sensitization phase aggravates experimental allergic airway inflammation. Eur. J. Immunol. 2010. 40: 2259-2266.
124. Weiss, J. M., Bilate, A. M., Gobert, M., Ding, Y., Curotto de Lafaille, M. A., Parkhurst, C. N., Xiong, H. et al., Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells. J. Exp. Med. 2012. 209: 1723-1742, S1721.
125. Kearley, J., Robinson, D. S. and Lloyd, C. M., CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J. Allergy Clin. Immunol. 2008. 122: 617-624 e616.
126. Kearley, J., Barker, J. E., Robinson, D. S. and Lloyd, C. M., Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J. Exp. Med. 2005. 202: 1539-1547.
127. Lewkowich, I. P., Herman, N. S., Schleifer, K. W., Dance, M. P., Chen, B. L., Dienger, K. M., Sproles, A. A. et al., CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J. Exp. Med. 2005. 202: 1549-1561.
128. Huang, M. T., Dai, Y. S., Chou, Y. B., Juan, Y. H., Wang, C. C. and Chiang, B. L., Regulatory T cells negatively regulate neovasculature of airway remodeling via DLL4-Notch signaling. J. Immunol. 2009. 183: 4745-4754.
129. Whitehead, G. S., Wilson, R. H., Nakano, K., Burch, L. H., Nakano, H. and Cook, D. N., IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J. Allergy Clin. Immunol. 2012. 129: 207-215 e201-205.
130. Hartl, D., Koller, B., Mehlhorn, A. T., Reinhardt, D., Nicolai, T., Schendel, D. J., Griese, M. et al., Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J. Allergy Clin. Immunol. 2007. 119: 1258-1266.
131. Smyth, L. J., Eustace, A., Kolsum, U., Blaikely, J. and Singh, D., Increased airway T regulatory cells in asthmatic subjects. Chest 2010. 138: 905-912.
132. Nguyen, K. D., Vanichsarn, C. and Nadeau, K. C., TSLP directly impairs pulmonary Treg function: association with aberrant tolerogenic immunity in asthmatic airway. Allergy Asthma Clin. Immunol. 2010. 6: 4.
133. Akbari, O., DeKruyff, R. H. and Umetsu, D. T., Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2001. 2: 725-731.
134. Hammad, H., Kool, M., Soullie, T., Narumiya, S., Trottein, F., Hoogsteden, H. C. and Lambrecht, B. N., Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J. Exp. Med. 2007. 204: 357-367.
135. Lombardi, V., Speak, A. O., Kerzerho, J., Szely, N. and Akbari, O., CD8alpha(+)beta(-) and CD8alpha(+)beta(+) plasmacytoid dendritic cells induce Foxp3(+) regulatory T cells and prevent the induction of airway hyper-reactivity. Mucosal. Immunol. 2012. 5: 432-443.
136. Soroosh, P., Doherty, T. A., Duan, W., Mehta, A. K., Choi, H., Adams, Y. F., Mikulski, Z. et al., Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance. J. Exp. Med. 2013. 210: 775-788.
137. Afshar, R., Strassner, J. P., Seung, E., Causton, B., Cho, J. L., Harris, R. S., Hamilos, D. L. et al., Compartmentalized chemokine-dependent regulatory T-cell inhibition of allergic pulmonary inflammation. J. Allergy Clin. Immunol. 2013. 131: 1644-1652.
138. Semmrich, M., Plantinga, M., Svensson-Frej, M., Uronen-Hansson, H., Gustafsson, T., Mowat, A. M., Yrlid, U. et al., Directed antigen targeting in vivo identifies a role for CD103+ dendritic cells in both tolerogenic and immunogenic T-cell responses. Mucosal Immunol. 2012. 5: 150-160.
139. Hill, D. A., Siracusa, M. C., Abt, M. C., Kim, B. S., Kobuley, D., Kubo, M., Kambayashi, T. et al., Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat. Med. 2012. 18: 538-546.
140. Olszak, T., An, D., Zeissig, S., Vera, M. P., Richter, J., Franke, A., Glickman, J. N. et al., Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012. 336: 489-493.
141. Herbst, T., Sichelstiel, A., Schar, C., Yadava, K., Burki, K., Cahenzli, J., McCoy, K. et al., Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am. J. Respir. Crit. Care Med. 2011. 184: 198-205.
142. Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C. et al., Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009. 461: 1282-1286.
143. Russell, S. L., Gold, M. J., Hartmann, M., Willing, B. P., Thorson, L., Wlodarska, M., Gill, N. et al., Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 2012. 13: 440-447.
144. Huang, Y. J., Nelson, C. E., Brodie, E. L., Desantis, T. Z., Baek, M. S., Liu, J., Woyke, T. et al., Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J. Allergy Clin. Immunol. 2011. 127: 372-381 e371-373.
145. Hart, T. K., Blackburn, M. N., Brigham-Burke, M., Dede, K., Al-Mahdi, N., Zia-Amirhosseini, P. and Cook, R. M., Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma. Clin. Exp. Immunol. 2002. 130: 93-100.
146. Wenzel, S., Wilbraham, D., Fuller, R., Getz, E. B. and Longphre, M., Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 2007. 370: 1422-1431.
147. Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M. et al., Lebrikizumab treatment in adults with asthma. N. Engl. J. Med. 2011. 365: 1088-1098.
148. Singh, D., Kane, B., Molfino, N. A., Faggioni, R., Roskos, L. and Woodcock, A., A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma. BMC Pulm. Med. 2010. 10: 3.
149. Hansbro, P. M., Scott, G. V., Essilfie, A. T., Kim, R. Y., Starkey, M. R., Nguyen, D. H., Allen, P. D. et al., Th2 cytokine antagonists: potential treatments for severe asthma. Exp. Opin. Investig. Drugs 2013. 22: 49-69.
150. Corren, J., Busse, W., Meltzer, E. O., Mansfield, L., Bensch, G., Fahrenholz, J., Wenzel, S. E. et al., A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma. Am. J. Respir. Crit. Care Med. 2010. 181: 788-796.
151. Wenzel, S., Ford, L., Pearlman, D., Spector, S., Sher, L., Skobieranda, F., Wang, L. et al., Dupilumab in persistent asthma with elevated eosinophil levels. N. Engl. J. Med. 2013. 368: 2455-2466.
152. Leckie, M. J., ten Brinke, A., Khan, J., Diamant, Z., O'Connor, B. J., Walls, C. M., Mathur, A. K. et al., Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000. 356: 2144-2148.
153. Kips, J. C., O'Connor, B. J., Langley, S. J., Woodcock, A., Kerstjens, H. A., Postma, D. S., Danzig, M. et al., Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am. J. Respir. Crit. Care Med. 2003. 167: 1655-1659.
154. Kolbeck, R., Kozhich, A., Koike, M., Peng, L., Andersson, C. K., Damschroder, M. M., Reed, J. L. et al., MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function. J. Allergy Clin. Immunol. 2010. 125: 1344-1353 e1342.
155. Parker, J. M., Oh, C. K., LaForce, C., Miller, S. D., Pearlman, D. S., Le, C., Robbie, G. J. et al., Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma. BMC Pulm. Med. 2011. 11: 14.
156. Lloyd, C. M. and Hawrylowicz, C. M., Regulatory T cells in asthma. Immunity 2009. 31: 438-449.
157. Arnold, I. C., Dehzad, N., Reuter, S., Martin, H., Becher, B., Taube, C. and Muller, A., Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J. Clin. Invest. 2011. 121: 3088-3093.
158. Lagranderie, M., Abolhassani, M., Vanoirbeek, J. A., Lima, C., Balazuc, A. M., Vargaftig, B. B. and yMarchal, G., Mycobacterium bovis bacillus Calmette-Guerin killed by extended freeze-drying targets plasmacytoid dendritic cells to regulate lung inflammation. J. Immunol. 2010. 184: 1062-1070.
159. Grainger, J. R., Smith, K. A., Hewitson, J. P., McSorley, H. J., Harcus, Y., Filbey, K. J., Finney, C. A. et al., Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-beta pathway. J. Exp. Med. 2010. 207: 2331-2341.
160. Schreiber, T. H., Wolf, D., Tsai, M. S., Chirinos, J., Deyev, V. V., Gonzalez, L., Malek, T. R. et al., Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation. J. Clin. Invest. 2010. 120: 3629-3640.
161. Mays, L. E., Ammon-Treiber, S., Mothes, B., Alkhaled, M., Rottenberger, J., Muller-Hermelink, E. S., Grimm, M. et al., Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism. J. Clin. Invest. 2013. 123: 1216-1228.
162. Choi, J. M., Shin, J. H., Sohn, M. H., Harding, M. J., Park, J. H., Tobiasova, Z., Kim, D. Y. et al., Cell-permeable Foxp3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation. Proc. Natl. Acad. Sci. USA 2010. 107: 18575-18580.
163. Akdis, C. A., Therapies for allergic inflammation: refining strategies to induce tolerance. Nat. Med. 2012. 18: 736-749.